NFL Biosciences SA

€0.34As of Sun 8 Nov 2026, 12:00 UTC
EPA:ALNFLHealthcare
Country France
PE (Fwd) •••
TSR 5Y CAGR (35.17%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.28
PE TTM —
TSR TTM (69.77%)
Mkt cap €4.359M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
€0.405
17.79%
(67.02%)
Hold 12|2|1|7|3
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.01
0.01
0.01
0.01
27.52%
17.33%
15.51%
16.60%
Revenue€M
0.572
0.565
0.580
0.580
4.54%
1.03%
2.11%
0.90%
Peers (US$4.895M)
Cap (US$)
PE
6.509M
—
5.049M
6.626x
Capital
TTM
5Y
10Y
Leveragex
0.536
0.099
0.087
EBIT/Intx
0.273
0.372
0.316
Own earn%
74.26
202.14
177.83
Sh yield%
38.71
54.09
53.98
Owners
Insiders/Inst%
1.79
84.53
Short interest%
4.09
SBC / revenue%
2.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
8–13
$1 testx
—
Incr. ROIC%
6